GE HealthCare (Nasdaq:GEHC) today announced its new Pristina Via mammography system designed to enhance the screening experience.
The Chicago-based company debuted the system at the Radiological Society of North America’s 2024 Annual Meeting. Pristina Via provides mammography technologists with a suite of sophisticated tools, according to a news release. These tools balance the demands of diagnostic accuracy and fast-paced workflows, facilitating more patient-centered breast care.
GE HealthCare notes that, amid a global shortage of technologists, the number of women seeking mammograms remains steady. Additionally, the company highlights an all-time high demand for more efficient and intelligent workflows.
Pristina Via brings advanced new features to help minimize repetitive tasks and streamline workflows. It enables mammography technologists to maintain their focus on providing quality, personalized care during the screening experience.
The system offers zero-click acquisition for faster, seamless workflows, plus no wait time between exposures. This enables technologists to work at their own speed, taking advantage of speedy image-to-image cycle time. Pristina Via also features vendor-neutral prior image comparison to reduce time spent analyzing previous exams. GE HealthCare said it offers the lowest radiation dose used for all breast thicknesses among major mammography systems, too.
Pristina Via also has a future-focused, scalable platform with full backward compatibility to provide imaging centers access to the latest capabilities while also providing flexibility to support the evolving needs of their sites.
“Pristina Via represents a significant evolution in our patient focused Senographe Pristina platform which was designed by women for women. With the new in-room workflow, Pristina Via minimizes laborious tasks and provides technologists with the gift of time to prioritize what matters most: compassionate, patient-centered care,” said Jyoti Gupta, president & CEO for Women’s Health and X-ray at GE HealthCare.
